Campbell & Co Investment Adviser’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-15,681
| Closed | -$548K | – | 1168 |
|
|
2024
Q4 | $548K | Buy |
+15,681
| New | +$548K | 0.04% | 625 |
|
|
2024
Q2 | – | Sell |
-94,772
| Closed | -$4.11M | – | 1180 |
|
|
2024
Q1 | $4.11M | Buy |
+94,772
| New | +$4.11M | 0.35% | 29 |
|
|
2023
Q4 | – | Sell |
-16,547
| Closed | -$751K | – | 1204 |
|
|
2023
Q3 | $751K | Buy |
+16,547
| New | +$751K | 0.09% | 368 |
|
|
2023
Q1 | – | Sell |
-15,018
| Closed | -$567K | – | 916 |
|
|
2022
Q4 | $567K | Buy |
+15,018
| New | +$567K | 0.14% | 252 |
|
|
2022
Q3 | – | Sell |
-11,299
| Closed | -$418K | – | 805 |
|
|
2022
Q2 | $418K | Buy |
+11,299
| New | +$418K | 0.11% | 336 |
|
|
2022
Q1 | – | Sell |
-17,346
| Closed | -$528K | – | 786 |
|
|
2021
Q4 | $528K | Sell |
17,346
-2,550
| -13% | -$77.6K | 0.18% | 181 |
|
|
2021
Q3 | $667K | Buy |
+19,896
| New | +$667K | 0.22% | 140 |
|
|
2020
Q1 | – | Sell |
-16,311
| Closed | -$985K | – | 261 |
|
|
2019
Q4 | $985K | Buy |
+16,311
| New | +$985K | 0.3% | 64 |
|
|
2019
Q3 | – | Sell |
-5,681
| Closed | -$365K | – | 672 |
|
|
2019
Q2 | $365K | Buy |
+5,681
| New | +$365K | 0.17% | 241 |
|
|
2017
Q3 | – | Sell |
-6,059
| Closed | -$308K | – | 407 |
|
|
2017
Q2 | $308K | Buy |
+6,059
| New | +$308K | 0.29% | 136 |
|